Hyperthermia and Controllable Free Radical Coenhanced Synergistic Therapy in Hypoxia Enabled by Near-Infrared-II Light Irradiation
Overview
Authors
Affiliations
Tumor cell metabolism and tumor blood vessel proliferation are distinct from normal cells. The resulting tumor microenvironment presents a characteristic of hypoxia, which greatly limits the generation of oxygen free radicals and affects the therapeutic effect of photodynamic therapy. Here, we developed an oxygen-independent free radical generated nanosystem (CuFeSe-AIPH@BSA) with dual-peak absorption in both near-infrared (NIR) regions and utilized it for imaging-guided synergistic treatment. The special absorption provides the nanosystem with high photothermal conversion efficiency and favorably matched photoactivity in both I and II NIR biological windows. Upon NIR light irradiation, the generated heat could prompt AIPH release and decompose to produce oxygen-independent free radicals for killing cancer cells effectively. The contrastive research results show that the enhanced therapeutic efficacy of NIR-II over NIR-I is principally due to its deeper tissue penetration and higher maximum permission exposure that benefits from a longer wavelength. Hyperthermia effect and the production of toxic free radicals upon NIR-II laser illumination are extremely effective in triggering apoptosis and death of cancer cells in the tumor hypoxia microenvironment. The high biocompatibility and excellent anticancer efficiency of CuFeSe-AIPH@BSA allow it to be an ideal oxygen-independent nanosystem for imaging-guided and NIR-II-mediated synergistic therapy systemic administration.
Gao Z, Mansor M, Howard F, MacInnes J, Zhao X, Muthana M Nanomaterials (Basel). 2025; 15(3).
PMID: 39940197 PMC: 11820260. DOI: 10.3390/nano15030221.
Hu L, Dong G, Li X, Li S, Lv Y RSC Adv. 2025; 15(5):3098-3109.
PMID: 39885853 PMC: 11780488. DOI: 10.1039/d4ra07841a.
Yang S, Hu T, Williams G, Yang Y, Zhang S, Shen J J Nanobiotechnology. 2024; 22(1):317.
PMID: 38849886 PMC: 11161954. DOI: 10.1186/s12951-024-02591-5.
Wu X, Zhou Z, Li K, Liu S Adv Sci (Weinh). 2024; 11(16):e2308632.
PMID: 38380505 PMC: 11040387. DOI: 10.1002/advs.202308632.
Photoresponsive Inorganic Nanomaterials in Oncology.
Barbero F, Gul S, Perrone G, Fenoglio I Technol Cancer Res Treat. 2023; 22:15330338231192850.
PMID: 37551087 PMC: 10408349. DOI: 10.1177/15330338231192850.